Rapid identification of compounds to treat neurodegenerative diseases Menlo Park, California – Alion Pharmaceuticals and LamdaGen Corporation announced today that the two biotechnology companies have entered into a Strategic Collaboration
Label-Free & Labeled Technology for Protein Characterization and Quantitation Sep 1, 2010By: Daniele Gerion, Gwo-Jen DayBioPharm InternationalVolume 23, Issue 9 We present a new label-free platform for protein characterization and
CRP is a cardio-biomarker which can assess risk for future heart attacks Menlo Park, CA — LamdaGen Corporation presented data on its work for the visual POC (Point of Care)
Early detection can save the dairy industry hundreds of millions of dollars each year. Menlo Park, CA — The scientific team at LamdaGen Corporation announced today that feasibility testing for